Hondramin - bioregulator of cartilaginous tissue.

Hondramin®- Bioregulator of cartilaginous tissue.

Normalizes the function of the musculoskeletal system, helps to restore cartilage and sustain joint function.

Diseases of the musculoskeletal system caused by disorders of the connective tissue and cartilage structures, are widely distributed in the population. The urgency of solving the problem effectively care for patients with this pathology is very high, as it often leads to a significant restriction of efficiency, but also to disability. Etiopathogenic factors contributing to the development of diseases of connective tissue structures, diverse, so to correct and prevent violations of connective tissue occurring in various diseases, designed "Hondramin." 

• Possesses selective effect on the cells of cartilage and improves metabolic processes in chondrocytes that protects joints from various lesions and normalizes their work. 
• Actively influence the recovery of the cartilage and connective tissues in arthritis, arthrosis, osteochondrosis, rheumatic diseases and injuries of the musculoskeletal system, reduces pain and joint stiffness. 
• Recommended with increased physical activities and sports, as well as the elderly to maintain the functions of the musculoskeletal system. 

Clinical trials of "Hondramin" conducted at 120 patients with osteoarthritis of the knee joints, spinal osteochondrosis and systemic osteoporosis. 

Evaluating the effectiveness of the use of "Hondramin" was based on the dynamics of subjective complaints and objective indicators of laboratory and instrumental studies, as well as monitoring the functional state of the musculoskeletal system.

During the clinical trials established that the course intake of "Hondramin" in the complex therapy helped to reduce pain and stiffness of joints at patients. The most characteristic action of "Hondramin" was to reduce pain and increase motion in the affected joints. While taking "Hondramin" all patients showed a significant smoothing of pathological symptoms, usually characterized by considerable resistance to therapy. The degree of clinical effect was dependent on the stage of the disease: in older and elderly trend was less pronounced, but such subjective feelings were assessed as very favorable for older patients.

"Hondramin" is recommended to speed recovery of cartilage tissue in inflammatory and degenerative lesions of the exchange-limb joints and spine, malnutrition, exposure of the body of various extreme factors, as well as heavy physical exercise and sports. "Hondramin" recommended to the senior and elderly to maintain the normal functioning of the musculoskeletal system.

Indications of use:

• Degenerative-dystrophic diseases of the joints of the limbs and spine;
• Consequences of injuries of joints and limbs;
• Arthropathy of various etiologies;
• Systemic connective tissue disease;
• Pre- and postoperative periods during operations on the joints;
• State after extreme physical exertion,
• Systemic prevention of bone and joint disorders in elite sport.

Dosing:

1-3 tablets 2-3 times a day for 10-15 minutes before meals with water without chewing. Course: 30-45 days. Repeat the course in 3-6 months.

Contraindications:

Individual intolerance to the product components, pregnancy, lactation.

Release form:

40 tablets per pack